+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Smoking cessation aid

Smoking cessation aids encompass a variety of interventions designed to help individuals quit smoking. These include pharmacological treatments, such as nicotine replacement therapy (NRT) and non-nicotine medications (e.g., bupropion, varenicline), as well as behavioral therapies like counseling and support groups. The goal is to reduce withdrawal symptoms, manage cravings, and provide strategies to overcome nicotine dependence, significantly increasing the likelihood of successful long-term abstinence from tobacco products.
Catalog No Product Description CAS No. Purity Structural Formula
BP0444
Cytisine
Cytisine is an organic heterotricyclic compound that is the toxic principle in Laburnum seeds and is found in many members of the Fabaceae (legume, pea or bean) family. An acetylcholine agonist, it is widely used throughout Eastern Europe as an aid to giving up smoking. It has a role as a phytotoxin, a nicotinic acetylcholine receptor agonist and a plant metabolite. It is an alkaloid, a lactam, an organic heterotricyclic compound, a bridged compound and a secondary amino compound. Cytisine is a nicotinic acetylcholine receptor agonist, has been widely used for central nervous system (CNS) diseases treatment. It is a partial agonist at alpha4/beta2 nAChRs, and a full agonist at alpha3/beta4 and alpha7 nAChRs, has antidepressant-like properties in several rodent models of antidepressant efficacy.
485-35-8 98% Cytisine
BP2008
Forsythoside I
Forsythoside I is a natural product from forsythia suspense (thunb.) vahl.
1177581-50-8 98% Forsythoside I
BP0212
Astragaloside III
Astragaloside III has anti-gastric ulcer effects, and exhibits strong growth-promoting effects in cultured GES-1 cells. Astragaloside III can effectively reduce cancer cell survival in vitro and inhibit the tumor growth in vivo, the potential mechanism is the induction of cell apoptosis signaling pathways, suggests that it provides a new therapeutic tool to treat breast cancer. Astragaloside III is a triterpenoid saponin that is cycloastragenol with a 2-O-beta-D-glucopyranosyl-beta-D-xylopyranosyl moiety attached at position 3 via a glycosidic linkage. It is a triterpenoid saponin and a disaccharide derivative. It is functionally related to a cycloastragenol.
84687-42-3 98% Astragaloside III
BP4036 86831-53-0 98% Rhodiolin
BP0838 17575-22-3 98% Lanatoside C